Top and emerging locations for M&A deals in the pharmaceutical industry
The data shows that M&A activity is strongest in the US, which saw a total of 19 deals announced in…
By
The data shows that M&A activity is strongest in the US, which saw a total of 19 deals announced in…
ByOur analysis of the data shows that pharmaceutical companies are currently hiring for digitalization jobs at a rate higher than…
BySome parts of the world are investing more heavily in fintech roles than others.
ByWe've analysed hiring patterns using data from GlobalData
ByWe've analysed companies' annual reports and other filings to see which key issues are receiving the most attention.
ByAnalysis of patent filings revealse the top companies for fintech related applications in the industry over the past year
ByThe health concern over COVID-19 in April 2022 decreased from March, shows the COVID-19 concern index, which is measured by…
The company updated the FY2022 financial guidance for adjusted diluted EPS to $6.25-$6.45.